what does epinephrine do to right atrial pressure

CONTENTS

• Rapid Reference 🚀
• Core agents
  • Inodilators (milrinone, dobutamine, isoproterenol)
  • Pure vasopressors
  • Inopressors (norepinephrine, epinephrine, dopamine)
• Peripheral vasopressors
• Midodrine
• Methylene Blueish
• Podcast
• Questions & word
• Pitfalls

---

rapid reference

(dorsum to contents)

---

---

inodilators

(back to contents)

---

classic inodilators (milrinone, dobutamine)

• Machinery
  • Dobutamine stimulates by and large beta-receptors, with very little stimulation of alpha-receptors.
  • Milrinone inhibits intracellular adenylyl cyclase, thereby increasing intracellular cyclic AMP levels.
• Physiologic event
  • Main outcome is positive inotropy, with positive chronotropy as well.
  • Secondary effect is peripheral vasodilation.
  • Cardiac output is increased due to both inotropic effect and vasodilation.
  • Upshot on blood pressure is variable, depending on how responsive the middle is to inotropy.  If the middle responds strongly (with increased stroke volume and middle charge per unit), it is possible for these drugs to increase blood pressure.  However, if the centre is already working as hard as information technology tin can, then the vasodilator effect may be dominant, causing a drop in blood pressure.  Overall, the effect on blood pressure is unpredictable.
• Clinical use
  • (1) Depression-output cardiogenic shock.  Care is required for patients with hypotension, since at that place is a risk of exacerbating hypotension.
  • (2) Septic stupor with inadequate cardiac output (every bit an add-on amanuensis).  Nevertheless, epinephrine could exist a superior choice in that situation, if blood pressure level is tenuous.
• How to titrate
  • Ideally, the inodilators should be titrated against cardiac output or a surrogate of cardiac output (eastward.m. urine output).
  • They shouldn't be titrated against blood force per unit area, because they have no predictable effect on blood pressure.
• Pro/con of different agents?
  • Milrinone causes a bit more vasodilation, and so it might exist better for cardiogenic shock.   Still, milrinone is renally eliminated, which can make it difficult to titrate in patients with renal failure.
  • Dobutamine is easier to titrate due to its curt half-life, and so information technology is frequently a preferred agent if the patient'south response to inotropy isn't entirely predictable.
  • Prolonged infusion of dobutamine may crusade desensitization of beta-receptors and reduced efficacy.  This may be a trouble, merely information technology can besides help wean the patient off dobutamine once the infusion has been running for a long time (it may exist easier to wean off than would be expected).

isoproterenol

• Mechanism:  Pure beta-agonist.
• Physiologic upshot:  Very powerful chronotrope, with positive inotropic effects every bit well.
• Clinical utilise:  Bradycardia (will work in some patients who are refractory to epinephrine).
• How to titrate:  typically, against heart rate.
• Pro/Con?
  • Isoproterenol is probably the most powerful chronotrope.
  • Information technology doesn't cause vasoconstriction, so information technology'south safety to give peripherally.
  • Its primary drawback is pricing & availability:  in the United States the price is astronomical and some hospitals don't have it.  If y'all don't accept it, epinephrine can unremarkably be used as an alternative agent.

---

pure vasopressors

(dorsum to contents)

---

vasopressin

• Machinery:  Stimulates V1 and V2 receptors, causing vasoconstriction and renal water retentiveness.
• Physiologic effects:
  • It increases systemic vascular resistance (SVR).
  • It does cause venoconstriction, which may increase preload.
  • Its dominant outcome on cardiac output is oftentimes to cause a reduction (but this may depend on the heart'due south ability to tolerate increased afterload).
• Clinical use:
  • Vasodilatory shock (peculiarly sepsis).  Typically given in depression doses (0-0.06 U/min), either as primary or secondary agent.(27483065)
  • Forepart-line amanuensis for hepatorenal syndrome (HRS) in countries defective terlipressin (such equally the United States).
  • Key diabetes insipidus (only very low doses are needed, eastward.yard. 0.01 units/minute or less).
  • Variceal gastrointestinal hemorrhage (theoretically an attractive agent, but pragmatically it'due south impossible to titrate adequately).
• How to titrate:  typically, confronting blood pressure.
• Pro/Con
  • Vasopressin may preferentially cause vasoconstriction of mail service-glomerular arterioles in the kidney, causing improvement in renal function.
  • Information technology may crusade some pulmonary vasodilation, which can be helpful in the context of pulmonary hypertension.
  • Vasopressin shouldn't generally be given peripherally (if information technology extravasates, there is no antidote).
  • Vasopressin tin can cause digital ischemia, especially when combined with norepinephrine – must pay careful attention to perfusion of hands and feet; shut off vasopressin at offset sign of ischemic digits .

phenylephrine

• Mechanism:  Pure blastoff-agonist, causes arterial and venous vasoconstriction.
• Physiologic event
  • Increased systemic vascular resistance (SVR).
  • Venoconstriction increases the preload.
  • Effect on cardiac output depends on preload-responsiveness versus ability of the centre to handle increased afterload.   For example, in a patient with systolic center failure and volume overload, added preload won't assistance, whereas the middle may be unable to tolerate afterload – and then the net effect is to reduce the cardiac output.   Alternatively, for a patient who is preload-responsive with a stronger ejection fraction, phenylephrine could cause a internet increase in cardiac output.
  • Available evidence in sepsis suggests that phenylephrine has a very similar physiologic effect compared to norepinephrine.🌊  Both agents are predominantly alpha-agonists.
  • Phenylephrine can crusade a mild reflex bradycardia due to elevation in blood pressure.
• Clinical employ:
  • Vasodilatory shock.
  • Useful in patients with critical aortic stenosis (who take a fixed afterload imposed on the left ventricle by the stenotic valve).
  • Atrial fibrillation with fast ventricular response (increases blood pressure while causing reflex reduction in heart rate).
• How to titrate: typically, against claret pressure level.
•  Pro/Con
  • It has classically been feared that phenylephrine would driblet the cardiac output.  This seems to occur with phenylephrine boluses, but not with infusions (available testify indicates that a phenylephrine infusion functions pretty similarly compared to a norepinephrine infusion).
  • It is safe to requite peripherally.
  • Phenylephrine is well-nigh 10 times less strong than norepinephrine (i.e. 10 mcg/min phenylephrine is roughly equivalent to 1 mcg/min norepinephrine).  Phenylephrine is mostly supplied equally a fairly dilute solution, which tin make this logistically problematic for patients requiring high-dose vasoconstriction.  Thus, phenylephrine monotherapy is largely restricted to patients with balmy to moderate vasodilatory shock due to logistic constraints.

---

inopressors

(back to contents)

---

norepinephrine

• Mechanism:  Predominantly an blastoff-agonist, with some beta-agonism as well.
• Physiology
  • Increases systemic vascular resistance (SVR), causes venoconstriction (increasing preload), and has an inotropic/chronotropic outcome.
  • Increases blood force per unit area and may increment urine output.
  • Tends to cause cardiac output to increase or remain stable (depending on how responsive the heart is to preload, afterload, and inotropy).
• Clinical use
  • Widely popular showtime-line amanuensis for a variety of shock states (septic shock, cardiogenic daze with severe hypotension).
  • Good "broad spectrum" vasoactive agent when it's unclear precisely what is going on.
• How to titrate:
  • Typically, against claret pressure level.
  • In that location is no "maximal dose" of norepinephrine.🌊
•  Pro/Con
  • Strong rails record in septic and cardiogenic shock.

epinephrine

• Mechanism:  At lower doses the beta-agonist furnishings may predominate; with ongoing up-titration in that location are increasing alpha-agonist furnishings likewise.
• Physiology
  • Causes chronotropy and inotropy, thereby increasing the cardiac output.
  • Increases systemic vascular resistance and also causes venoconstriction (increasing preload).
  • Stabilizes mast cells, blocking the pathophysiology of anaphylaxis.
  • Beta-ii agonist stimulation causes bronchodilation, decreases potassium levels, and stimulates the generation of aerobic lactate production by the liver.  This is often feared, only lactate may be used as a metabolic fuel past the heart, and so this mechanism of action is probably benign (in the absence of profound pre-existing metabolic acidosis).🌊
• Clinical uses
  • (i) Bradycardia and bradycardic daze (given inotropic effects).
  • (two) Septic shock (shown in the 🐱True cat trial to be an adequate culling to norepinephrine).(18654759)  Information technology seems to work especially well in patients with inappropriately depression middle charge per unit and/or low cardiac output, who probable have a poor sympathetic response to sepsis.🌊
  • (three) At low doses (below v-10 mcg/kg/min), the predominant event is equally an inotrope, and so it can exist used for patients with low-output cardiogenic shock.  Compared to dobutamine/milrinone, low-dose epinephrine has a touch of blastoff-activeness which will tend to prevent hypotension.
  • (4) Push button-dose epinephrine is useful for patients crashing from a variety of causes (east.1000. bradycardic peri-abort).  Epinephrine is generally a good pick for the most-expressionless patient.🌊
  • (5) First-line agent for anaphylaxis.   Annotation that epinephrine may be indicated for handling for anaphylaxis fifty-fifty if the hemodynamics are stable.📖
• How to titrate:  depends on clinical awarding.
•  Pro/Con
  • Epinephrine is a powerful drug with established efficacy in sepsis, as well useful in bradycardia and cardiogenic shock.
  • The master business is that at high doses for long periods of fourth dimension, it may promote a stress cardiomyopathy.
  • It causes lactate production which isn't dangerous (may be physiologically benign).🌊  However, practitioners must be enlightened of this issue; otherwise they may senselessly chase lactate values.
  • Epinephrine causes a small decrease in potassium, which is generally not a problem.  Effects on potassium may exist useful in patients with hyperkalemia and bradycardia (e.g., BRASH syndrome 📖).

dopamine

• Mechanism/physiology
  • Dopamine hits a variety of receptors at unlike dose ranges ("dirty" drug).
  • Information technology's oft difficult to figure out what it is doing to your patient.  For example, low-dose dopamine tin really cause hypotension (due to a predominant upshot of vasodilation), which can make it difficult to wean off the dopamine.
• Reasons dopamine should be abased:
  1. Dopamine increases bloodshed in RCTs:   Dopamine increased bloodshed compared to norepinephrine in the subgroup of patients with cardiogenic shock.(20200382)  It besides increased mortality compared to epinephrine among septic children.(26323041)
  2. It'due south often impossible to figure out what dopamine is doing (given the variety of dissimilar effects at different doses in different patients).   This makes it impossible to titrate in whatsoever rational fashion (upwards-titration may cause dopamine to office via a different mechanism entirely).
  3. Dopamine has unique adverse endocrine furnishings.
  4. Dopamine may directly stimulate diuresis via action on dopamine-receptors, thereby falsely suggesting that renal perfusion is adequate.
  5. There is a relatively high take chances of tissue necrosis if it extravasates.
  6. Better agents exist:  at that place is cypher dopamine does that tin't be accomplished with the utilize of norepinephrine and/or epinephrine.
  7. Dopamine may crusade greater malperfusion of the gut compared to norepinephrine.

---

peripheral pressors

(dorsum to contents)

---

peripheral IV line

• Hemodynamic stabilization should never wait until central access is obtained.  Thus, peripheral vasopressors should exist started immediately if the blood pressure or perfusion is inadequate.
• Norepinephrine is rubber for brusk periods of time through a big peripheral vein.  Ongoing peripheral infusion besides appears safe, but this should ideally be done inside the context of a well-designed protocol involving frequent monitoring of the extremity and preparation for management of extravasation reaction.🌊  Ongoing infusion should be avoided in deep ultrasound-guided peripheral IVs, where information technology may be incommunicable to monitor the tissue surrounding the end of the 4 cannula.
• Phenylephrine and epinephrine take not been reported to crusade tissue necrosis.  Peripheral infusion of these agents appears to be by and large safe, although this should withal ideally be done via a well-functioning cannula proximal to the wrist.🌊
• Vasopressin should arguably be avoided for peripheral assistants, considering if it extravasates there is no vasodilatory agent which can annul its activity.

midline catheter

• These are catheters placed in the arm, like to a PICC, merely shorter (typically ten-xx cm in length, terminating before the shoulder).
• Clinician-placed midlines are evolving as an alternative to either ultrasound-guided peripheral IVs or central lines.
• This is a rapidly emerging topic.  Overall, vasopressor administration via midline catheters appears to exist safe.🌊

---

midodrine

(back to contents)

---

basics

• Oral alpha-1 agonist, which acts as a pure vasopressor.

more than common clinical indications in critical care:

• Cirrhosis & hepatorenal syndrome
  • Midodrine is a component of oral therapy for hepatorenal syndrome.
  • Some evidence suggests that ongoing midodrine therapy in patients with cirrhosis may back up renal perfusion (given that these patients suffer from chronic vasodilation).
• 🛑 Accelerated weaning from vasopressors
  • ⚠️ The MIDAS trial suggests that midodrine is not effective at accelerating the weaning off Four vasopressors amidst most ICU patients.🌊 (32885276)
  • ⚠️  Currently, best available evidence indicates that midodrine should not be used to hasten weaning off vasopressor infusions among non-cirrhotic patients.

dose

• The usual starting dose is ten mg PO q8hr. Brand sure the drug is dosed q8hr and not "three times daily with meals," which is what the computer may default to.
• Dose range is 5-40 mg q8hr.(26953217)
• Midodrine is cleared by the kidney, so practise caution in renal dysfunction.

contraindications/cautions

• Reflex bradycardia tin can occur.

---

methylene bluish

(back to contents)

---

mechanisms of action

• (ane) Methylene blue causes vasoconstriction past inhibiting nitric oxide synthase.
  • This is a potentially unsafe way to increment claret pressure, because it could potentially impair microvascular perfusion.
  • Historically, a nitric oxide synthesis inhibitor was shown to increment mortality in septic shock.(14707556)
• (2) Methylene blue inhibits the conversion of guanine triphosphate to cGMP (an intracellular signaling molecule which increases vasodilation).
• (3) Methylene blue may be able to have electrons from NADH and transfer them to cytochrome C in the mitochondria, thereby bypassing parts of the electron ship chain.  This could restore mitochondrial function in some situations where parts of the electron send chain are dysfunctional, for instance metformin toxicity.(28840449)

more than common indications

• Refractory vasoplegic shock of whatsoever etiology.
  • Specially following cardiothoracic surgery.
  • Perhaps also:  septic shock, anaphylaxis.
• Metformin poisoning.📖

dosing

• #1)  Test dose of 2 mg/kg infused over 15 minutes.
  • If no response, and so try some other medication or treatment strategy.
  • If response seen, and so consider initiating an infusion…
• #2)  Infusion:
  • Dose range from 0.25 – 2 mg/kg/hour.
  • May be connected for up to 48-72 hours.  Wean off when hemodynamics amend.

potential adverse furnishings / contraindications

1. Inhibition of cGMP may increase pulmonary vascular resistance, thereby impairing right ventricular function and impairing oxygenation.  This may be more of a trouble at higher doses.
2. High levels of methylene bluish can interfere with pulse oximetry (a problem by and large when giving the bolus dose).
3. Methylene bluish can act as an oxidizing amanuensis at loftier doses (east.g., >vii mg/kg).  This may cause methemoglobinemia.  In patients with G6PD deficiency, this could also cause hemolytic anemia.
4. Methylene bluish inhibits monoamine oxidase A (MAO), thereby increasing brain serotonin levels.  This could crusade serotonin syndrome in the presence of other serotonergic agents.
5. Methylene blue may inhibit CYP enzyme metabolism, leading to accumulation of some medications (e.g. digoxin, warfarin, fentanyl).
6. Methylene blue is contraindicated in pregnancy (due to a potential for placental vasoconstriction and fetal hypoxemia).

---

podcast

(back to contents)

---

Follow usa on iTunes

---

questions & word

(back to contents)

---

To keep this page small and fast, questions & word near this post tin can exist institute on some other page here .

• Any use of dopamine (there are better agents).
• Failure to aggressively up- and down-titrate vasopressors to decide the physiologic effect of each on any specific patient.  Medications may non behave as described in a textbook (even this book!).  By continually adjusting infusion rates, information technology is often possible to get a sense of which agents are most effective.  The goal is always to use the minimal full dose of vasopressors necessary to accomplish hemodynamic targets, so if a drug doesn't seem to be having any effect then wean information technology off.
• Ongoing infusion of vasopressin despite show of malperfused digits.
• Backlog use of vasopressors (especially the combination of norepinephrine and vasopressin), which can lead to a phenomenon of iatrogenic vasoconstrictive stupor in patients with poor cardiac function (wherein excessive vasoconstriction causes a drop in cardiac output, causinglow cardiac output and daze).  Beware of this phenomenon.  When encountered, consider the addition of epinephrine and down-titration of vasoconstrictors.
• Use of agents with beta-agonist activity in patients with atrial fibrillation and rapid ventricular response.
• Failure to up-titrate norepinephrine beyond arbitrary "upper limits" imposed by hospitals or local culture (at that place is really no upper limit on the norepinephrine dose).
• Fright of using epinephrine due to concerns that it may increase the lactate (increased lactate levels due to epinephrine are probably beneficial in well-nigh cases).
• Delaying vasopressor initiation until cardinal access is obtained (instead, peripheral vasopressor infusion should exist used to immediately stabilize the patient).

Guide to emoji hyperlinks

Going farther

• Pressor overview
  • EMCrit RACC 138
• Pure pressors
  • Alternative viewpoint on phenylephrine infusions
• Epinephrine & lactate
  • Epinephrine & significance of lactate
• Titration & selection issues
  • Why we fail at hemodynamics: cerebral errors
  • Epinephrine responsiveness & challenge
• Peripheral pressors & midlines
  • Peripheral pressors (EMCrit RACC 107)
  • Are peripheral vasopressors rubber (Salim Rezaie, RebelCast)
  • Phenylephrine & epinephrine tin be infused peripherally
  • Midlines:  EMCrit RACC role one & part 2.
• Vasopressin
  • Vasopressin… & renal microvascular hemodynamics
  • Vasopressin, vepinephrine, & VANISH
  • VANCS trial: vasopressin for post-CABG daze

References

• 14707556   López A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts Southward, Brockway G, Anzueto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Arneson C, Grove G, Grossman Southward, Grover R. Multiple-center, randomized, placebo-controlled, double-bullheaded study of the nitric oxide synthase inhibitor 546C88: result on survival in patients with septic shock. Crit Care Med. 2004 January;32(1):21-30. doi: 10.1097/01.CCM.0000105581.01815.C6  [PubMed]
• 18654759   Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J; CAT Study investigators. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Intendance Med. 2008 Dec;34(12):2226-34. doi: 10.1007/s00134-008-1219-0  [PubMed]
• 20200382   De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL; Soap II Investigators. Comparison of dopamine and norepinephrine in the handling of daze. North Engl J Med. 2010 Mar 4;362(9):779-89. doi: 10.1056/NEJMoa0907118  [PubMed]
• 26323041   Ventura AM, Shieh HH, Bousso A, Góes PF, de Cássia F O Fernandes I, de Souza DC, Paulo RL, Chagas F, Gilio AE. Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as First-Line Vasoactive Drugs in Pediatric Septic Shock. Crit Care Med. 2015 Nov;43(11):2292-302. doi: x.1097/CCM.0000000000001260  [PubMed]
• 26953217   Whitson MR, Mo E, Nabi T, Healy L, Koenig S, Narasimhan Grand, Mayo PH. Feasibility, Utility, and Safety of Midodrine During Recovery Phase From Septic Shock. Breast. 2016 Jun;149(half dozen):1380-3. doi: 10.1016/j.breast.2016.02.657  [PubMed]
• 27483065   Gordon Air conditioning, Stonemason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya Hd, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ; VANISH Investigators. Issue of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. JAMA. 2016 Aug 2;316(five):509-18. doi: 10.1001/jama.2016.10485  [PubMed]
• 28840449   Tucker D, Lu Y, Zhang Q. From Mitochondrial Part to Neuroprotection-an Emerging Role for Methylene Blue. Mol Neurobiol. 2018 Jun;55(6):5137-5153. doi: 10.1007/s12035-017-0712-2  [PubMed]
• 32885276   Santer P, Anstey MH, Patrocínio Doc, Wibrow B, Teja B, Shay D, Shaefi S, Parsons CS, Houle TT, Eikermann M; MIDAS Study Grouping. Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive intendance unit (MIDAS): an international randomised clinical trial. Intensive Care Med. 2020 Oct;46(10):1884-1893. doi: 10.1007/s00134-020-06216-10  [PubMed]

The Internet Book of Critical Intendance is an online textbook written by Josh Farkas (@PulmCrit), an associate professor of Pulmonary and Disquisitional Intendance Medicine at the University of Vermont.

fritschwifirs45.blogspot.com

Source: https://emcrit.org/ibcc/pressors/

Share this post